Pacific Biosciences of California (NASDAQ:PACB) and Scientific Industries (OTCMKTS:SCND) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Dividends

Scientific Industries pays an annual dividend of $0.05 per share and has a dividend yield of 1.2%. Pacific Biosciences of California does not pay a dividend.

Institutional & Insider Ownership

73.0% of Pacific Biosciences of California shares are held by institutional investors. 13.4% of Pacific Biosciences of California shares are held by company insiders. Comparatively, 33.4% of Scientific Industries shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Pacific Biosciences of California and Scientific Industries’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pacific Biosciences of California -110.10% -91.12% -59.60%
Scientific Industries 2.21% 3.63% 2.82%

Analyst Ratings

This is a summary of current recommendations and price targets for Pacific Biosciences of California and Scientific Industries, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pacific Biosciences of California 0 2 1 0 2.33
Scientific Industries 0 0 0 0 N/A

Pacific Biosciences of California presently has a consensus target price of $6.10, suggesting a potential downside of 18.99%. Given Pacific Biosciences of California’s higher possible upside, equities research analysts clearly believe Pacific Biosciences of California is more favorable than Scientific Industries.

Volatility & Risk

Pacific Biosciences of California has a beta of 2.63, indicating that its share price is 163% more volatile than the S&P 500. Comparatively, Scientific Industries has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500.

Valuation and Earnings

This table compares Pacific Biosciences of California and Scientific Industries’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pacific Biosciences of California $93.47 million 12.00 -$92.18 million ($0.87) -8.66
Scientific Industries $8.48 million 0.75 -$160,000.00 N/A N/A

Scientific Industries has lower revenue, but higher earnings than Pacific Biosciences of California.

Pacific Biosciences of California Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distribution partners in Asia, the Middle East, and Latin America. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

Scientific Industries Company Profile

Scientific Industries, Inc. provides benchtop laboratory equipment, customized catalyst research instruments, and bioprocessing systems and products worldwide. It offers vortex mixers to mix the contents of test tubes, beakers, and other containers by placing such containers on a rotating cup or other attachments; various mixers and shakers, such as high speed touch mixers, mixers with an integral timer, cell disruptors, microplate mixers, vortex mixers incorporating digital control and display, and multi-vessel vortex mixers and orbital shakers. The company also provides benchtop multi-purpose rotators and rockers to rotate and rock various containers; refrigerated incubators and incubator shakers for shaking and stirring functions; and magnetic stirrers, including high/low programmable magnetic stirrers, four-place high/low programmable magnetic stirrers, and large volume magnetic and four-place general purpose stirrers in analog and digital versions. In addition, it offers AMI-300 catalyst characterization instrument for temperature-programmed catalyst characterization experiments; and catalyst research instrument products, such as reactor systems, high throughput systems, and micro-activity reactors. Further, the company provides bioprocessing systems comprising coaster systems using disposable sensors for vessels with volumes ranging from 250 milliliter to 5 liters; and mechanical balances, moisture analyzers, and force gauges, as well as pharmacy, laboratory, and industrial digital scales. Its products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, petrochemical companies, and other industries performing laboratory-scale research. The company markets its products under the Genie and Torbal brand names directly, as well as through laboratory equipment distributors and online. Scientific Industries, Inc. was founded in 1954 and is headquartered in Bohemia, New York.

Receive News & Ratings for Pacific Biosciences of California Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pacific Biosciences of California and related companies with MarketBeat.com's FREE daily email newsletter.